There’s been a lot of mixed news about the AstraZeneca vaccine over the past months. In some countries in Europe, the vaccine was put on pause, while other countries never stopped using it. Now, there is new data out: According to a clinical trial conducted in the US, AstraZeneca’s vaccine was found to be 79% effective. Host Marco Werman talks with Dr. Miguel Nicolelis, based in São Paulo, Brazil.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?